NYSE$AMN

AMN Healthcare Services Inc. · Q4 2020 earnings

Q4 2020 earnings · · Investor relations

Briefing

AMN Healthcare reported an 8% increase in quarterly revenue, reaching $631 million, with adjusted EPS of $1.00.

AMN Healthcare announced Q4 2020 results with revenue of $631 million, up 8% year-over-year. GAAP EPS was $0.19, and adjusted EPS was $1.00. The company experienced record demand for nurse and allied staffing and significant growth in locum tenens and interim leadership during the quarter. All three reportable segments exceeded revenue guidance.

  • AMN transformed its business to respond to pandemic challenges and evolved its commitment to equality and social justice.
  • The AMN team extended core solutions and created new, technology-enabled services to help healthcare organizations deal with unprecedented volatility in labor demand.
  • Full year revenue reached a record high in 2020 with 2% organic growth despite disruption to many of our businesses from the pandemic.
  • All three reportable segments exceeded revenue guidance in the fourth quarter and carried strong momentum into 2021.

Headline financials

Total Revenue

$631M

Previous: $587M+7.6%
EPS (adj)

$1.00

Previous: $0.85+17.6%
Capital Expenditures

$10.3M

Previous: $10.4M-0.9%
Free Cash Flow

$29.5M

Previous: $68.2M-56.8%
Net Income

$9M

Previous: $27M-66.7%
Operating Income

$29M

Previous: $47M-38.3%
Gross Profit

$208M

Previous: $197M+5.3%
Cash & Equivalents

$29.2M

Previous: $83M-64.8%
Total Assets

$2.35B

Previous: $1.93B+21.8%
Stock-Based Comp

$5.42M

Previous: $4.53M+19.7%

Revenue & EPS history

AMN Healthcare · Revenue · Quarterly

$631M

Q4 2020+7.6%vs Q4 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

AMN Healthcare · $631M total across 3 segments · Q4 2020

  • Nurse & Allied Solutions
    $448M+15.2%
  • Physician & Leadership
    $111M
  • Technology & Workforce
    $72M

Forward guidance

AMN Healthcare projects revenue between $800 and $820 million for Q1 2021, with a gross margin between 31.5% and 32.0% and an adjusted EBITDA margin between 14.3% and 14.7%. They are projecting 33-36% year-over-year revenue growth in the first quarter of 2021.

Tailwinds

  • Consolidated revenue $800 - $820 Million
  • Gross margin 31.5% - 32.0%
  • SG&A as percentage of revenue 18.3% - 18.6%
  • Operating margin 10.3% - 10.7%
  • Adjusted EBITDA margin 14.3% - 14.7%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2020

Historical avgQ4 2020

-0.0%

Avg return

Earnings day

-1.9%

Avg return

5 days after

-0.6%

Avg return

30 days after

52%

34 / 66 earnings

Positive

+29.2%

Q1 2026

Best reaction

-29.5%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+29.2%+38.5%+41.5%
Q4 2025+11.4%+15.8%+4.2%
Q3 2025-3.4%-10.0%-11.8%
Q2 2025+2.3%+10.2%+23.2%
Q1 2025+8.2%+7.1%+3.8%
Q4 2024+6.7%+0.5%-6.8%
Q3 2024-29.5%-36.7%-36.2%
Q2 2024-3.1%-11.9%-24.0%
Q1 2024-9.3%+3.4%-10.1%
Q4 2023-20.9%-25.5%-24.7%
Q3 2023-12.2%-17.7%-9.5%
Q2 2023-16.4%-16.6%-18.6%
Q1 2023+7.7%+10.3%+18.0%
Q4 2022-4.0%-2.3%-13.4%
Q3 2022-7.5%-0.4%+1.7%
Q2 2022+1.8%-1.7%-12.7%
Q1 2022-8.2%-10.6%-1.3%
Q4 2021+8.8%+5.3%+10.4%
Q3 2021-8.2%-1.4%+3.7%
Q2 2021+5.4%+3.8%+15.4%
Q1 2021+7.6%+10.3%+11.0%
Q4 2020+4.1%-0.7%+1.4%
Q3 2020-5.8%-7.0%-1.9%
Q2 2020+4.8%-4.5%-1.7%
Q1 2020-9.3%-12.1%+13.0%
Q4 2019+9.6%+5.6%+4.0%
Q3 2019-0.5%+2.1%+0.8%
Q2 2019+7.7%+11.4%+15.5%
Q1 2019+1.9%-0.4%-6.0%
Q4 2018-12.5%-14.7%-26.7%
Q3 2018+13.3%+11.6%+23.9%
Q2 2018-15.2%-10.4%-5.4%
Q1 2018-21.9%-21.6%-14.6%
Q4 2017+4.8%+4.8%+10.9%
Q3 2017-3.6%-1.6%+16.3%
Q2 2017+1.1%+6.9%+4.4%
Q1 2017-6.8%-6.2%-9.0%
Q4 2016+4.0%+7.9%+10.3%
Q3 2016-1.6%-2.7%-7.8%
Q2 2016-11.9%-13.8%-13.5%
Q1 2016+1.0%
Q4 2015+1.8%
Q3 2015+5.9%
Q2 2015+0.1%
Q1 2015-1.4%
Q4 2014+2.0%
Q3 2014-1.7%
Q2 2014+5.7%
Q1 2014+3.8%
Q4 2013+1.4%
Q4 2012+13.4%
Q3 2013+13.4%
Q2 2013+6.1%
Q1 2013-1.3%
Q3 2012+4.0%
Q2 2012+5.5%
Q1 2011+19.4%
Q1 2012+6.1%
Q4 2011-2.0%
Q4 2009-2.0%
Q3 2011-3.7%
Q3 2010-3.7%
Q4 2010-1.4%
Q2 2010-1.4%
Q2 2011-1.4%
Q1 2010-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro